GlaxoSmithKline | GSK - Ação





Ação Alterar Data
AbbVie USD 5.31B 178M 2026-09
Alcon AG USD 2.44B 47M 2026-03
Almirall EUR 178.13M 1.54M 2025-12
Amgen USD 6.39B 169M 2026-09
argenx SE USD 371M 102.53M 2026-06
AstraZeneca USD 6.93B 362M 2026-06
Bayer EUR 11.97B 43M 2026-06
Biogen USD 2.22B 159.9M 2026-09
Bristol-Myers Squibb USD 2.7B 33M 2026-09
Eli Lilly USD 18.19B 1.4B 2026-09
Fresenius EUR 2.77B 43M 2026-06
Fresenius Medical Care EUR 2.33B 28.84M 2026-06
Genmab DKK 21M 8M 2026-03
Gilead Sciences USD 1.9B 57M 2026-09
GlaxoSmithKline GBP 6.28B 125M 2026-06
Glaxosmithkline GBP 6.3B 143M 2026-09
GRIFOLS EUR 3.49B 34M 2026-06
Hikma Pharmaceutical USD 1.11B 24M 2025-12
Lakefront Biotherapeutics EUR 17.69M 4.8M 2026-03
Lonza CHF 1.68B 163M 2025-12
Merck EUR 4.78B 220M 2026-03
Merck USD 6.16B 43M 2026-09
Novartis USD 6.1B 116M 2026-09
Novo Nordisk DKK 45.65B 21.26B 2025-06
Orion EUR 545.5M 33.3M 2026-09
Pfizer USD 10.02B 77M 2026-09
Philips EUR 3.22B 106M 2026-06
Recordati EUR 550.34M 4.52M 2026-06
Regeneron Pharmaceuticals USD 2.89B 189.7M 2026-09
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 24.12B 620M 2026-06
UCB EUR 1.31B 173M 2024-12